AERI - Aerie Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue24,181---
Cost of Revenue27,18616,7109,772-
Gross Profit-3,005-16,710-9,772-
Operating Expenses
Research Development86,12372,07852,39444,451
Selling General and Administrative120,61456,90534,70630,635
Non Recurring----
Others----
Total Operating Expenses233,923145,69396,87275,086
Operating Income or Loss-209,742-145,693-96,872-75,086
Income from Continuing Operations
Total Other Income/Expenses Net-22,824-1,170-1,994862
Earnings Before Interest and Taxes-209,742-145,693-96,872-75,086
Interest Expense-2,531-2,368-2,537-2,493
Income Before Tax-232,566-146,863-98,866-74,224
Income Tax Expense3-1,758193139
Minority Interest----
Net Income From Continuing Ops-232,569-145,105-99,059-74,363
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-232,569-145,105-99,059-74,363
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-232,569-145,105-99,059-74,363